A recent study from ETF Channel reveals that Amgen Inc (AMGN) is ranked #17 among 30 stocks in the Dow Jones Industrial Average based on analyst recommendations. However, it holds a better position in the broader S&P 500 index, sitting at #198 out of 500 stocks.
As of midday Tuesday, Amgen’s stock is up approximately 2.2%. It operates within the Biotechnology sector, alongside companies like Thermo Fisher Scientific Inc (TMO), which is up about 1.5%, and Gilead Sciences Inc (GILD), trading up by around 1.8%.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
